CHARGE DENSITY STUDY OF AN ANTITHROMBOTIC DRUG - NEW ASPECTS IN DRUG DESIGN.

被引:0
|
作者
Flaig, R. [1 ]
Luger, P. [1 ]
Soyka, R. [2 ]
Koritsanszky, T. [3 ]
机构
[1] Free Univ Berlin, Inst Kristallog, Takustr 6, D-14195 Berlin, Germany
[2] Boehringer Ingelheim Pharma KG, Biberach, Germany
[3] Univ Witwatersrand, Dept Chem, Private Bag 3, ZA-2050 Johannesburg, South Africa
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
P06.13.012
引用
收藏
页码:516 / 516
页数:1
相关论文
共 50 条
  • [31] Catalytic chelators: Mechanism and implications for drug design.
    Chong, CR
    Auld, DS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U212 - U212
  • [32] Advances in antiviral drug design. Volume 3
    Kelly, Terence A.
    1600, ACS, Washington, DC, USA (122):
  • [33] Shape signatures and receptor based drug design.
    Tian, LF
    Zauhar, RJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U528 - U529
  • [34] Protein family clustering as an aid to drug design.
    Sitkoff, DF
    Krystek, SR
    Bassolino, DA
    Cheney, DL
    Davis, ME
    Loughney, D
    Mason, JS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U425 - U425
  • [35] Discovery of risedronate: An interdisciplinary approach in drug design.
    Zurich, ML
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U34 - U34
  • [36] Catalytic chelators: Mechanism and implications for drug design.
    Chong, CR
    Auld, DS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U833 - U833
  • [37] MODULATION OF THE ARACHIDONATE METABOLISM - NEW ASPECTS FOR DRUG DESIGN
    FLOHE, L
    LOSCHEN, G
    ALLERGOLOGIE, 1982, 5 (04) : 156 - 168
  • [38] Atomic index of charge and orbital controlled intermolecular interaction in molecular modeling for QSAR in drug design.
    Bersuker, IB
    Bahceci, S
    Boggs, JE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U594 - U594
  • [39] PHASE TRANSITIONAL BEHAVIOR AND CHARGE DENSITY STUDY OF DRUG METHIMAZOLE
    Fayzullin, Robert R.
    Zakharychev, Dmitry V.
    Saifina, Alina F.
    Shteingolts, Sergey A.
    Lodochnikova, Olga A.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2019, 75 : E367 - E367
  • [40] A mathematical programming approach to DHFR inhibitor drug design.
    Karalapakkam, AK
    Achenie, LEK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U696 - U696